Re­ci­pharm CEO an­tic­i­pates 2024 will be ‘as hard’ for CD­MOs, strat­e­gy will be key for en­durance

Re­ci­pharm CEO Marc Funk an­tic­i­pates 2024 to be just as chal­leng­ing for CD­MOs in terms of find­ing op­por­tu­ni­ties for growth due to wider eco­nom­ic chal­lenges.

“Next year is go­ing to be, with re­gret, equal­ly as hard,” Funk told End­points News in an in­ter­view. “If your [prof­it] mar­gin is eat­en by in­fla­tion or ma­te­r­i­al costs in­crease, it’s dif­fi­cult to make the right prof­itabil­i­ty to have enough mon­ey to do in­vest­ments, and this is a bat­tle that we have to fight,” he added.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER